NASDAQ:AVLN | Income Statement | Avalyn Pharma Inc.

Complete source-backed income-statement history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$24.73M$31.29M-$31.29M$2.36M-$28.94M-$0.98-$0.9829,650,66029,650,660
2026-03-31$22.89M$27.91M-$27.91M$1.04M$0.00-$26.87M-$21.83-$21.831,230,6981,230,698
2025-06-30$17.88M$21.78M-$21.78M$1.59M-$20.19M-$17.63-$17.631,145,3091,145,309
2025-03-31$15.32M$18.72M-$18.72M$1.21M$0.00-$17.5M-$63.24-$63.24276,792276,792

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares